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Background
There are very few data evaluating prospectively the
bone mass and quality determinants using dual energy
X-ray absorptiometry (DXA), peripheral quantitative
computed tomography (pQCT), and ultrasound (US) in
JIA.
Aim
To evaluate bone mass and quality determinants, and to
identify the main predictors of reduced Bone Mineral
Density (BMD) and bone quality using these techniques
in JIA.
Methods
One hundred and fifty-one patients (median 15.6, range
9.7 to 35.2 years; 101 oligoarticular, 30 polyarticular, 15
systemic, and 15 enthesitis-related–arthritis onset
[ERA]) were evaluated. Of these, fifty-nine consecutive
patients were followed-up with a second evaluation. The
data obtained were compared with 80 ages- and sex-
matched healthy subjects.
Results
At the first evaluation, JIA patients showed a reduced
s p i n ea B M DS D Sv a l u ei nc o m p a r i s o nt oc o n t r o l s( p<
0.005). JIA patients showed also significant musculoske-
letal deficits, with lower levels of TrabBMD (p <
0.0001), muscle CSA (p < 0.005), SSIp (p < 0.05), and
significantly increased levels of fat CSA than controls (p
< 0.0001). Finally, JIA patients presented a significantly
reduced AD-SoS (p < 0.001), and QUS z-score (p <
0.005). These data were confirmed also in longitudinal
evaluation. However, evaluating different treatments, we
showed a significant negative correlation among aBMD
value (p < 0.005), TrabBMD (p < 0.005), AD-SoS (p <
0.005), and systemic corticosteroids exposure or intra-
articular corticosteroids injections, and a positive corre-
lation among TNF-alpha-blocking agents and aBMD (p
< 0.005), TrabBMD (p < 0.005), and AD-SoS (p <
0.005).
Conclusions
Pts with JIA have a low bone mass and quality in com-
parison to controls, and do not reach the normal condi-
tion over time despite the current more effective drugs.
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